Jj. Canales et Sd. Iversen, Psychomotor-activating effects mediated by dopamine D-2 and D-3 receptors in the nucleus accumbens, PHARM BIO B, 67(1), 2000, pp. 161-168
The contribution made by specific dopamine receptor subtypes to the inducti
on of motor behaviors has not been firmly established. Here, we first chara
cterized the behavioral effects induced by a D-2-class receptor agonist, br
omocriptine, following injections into the nucleus accumbens (Acb). Bromocr
iptine showed an atypical D-2-class receptor agonist profile, having no obs
ervable effect on a range of motor behaviors. However, when coadministered
with the D-1-class receptor agonist SKF 38393, bromocriptine showed a typic
al D-2-class receptor agonist profile, enhancing locomotor activity and sup
pressing spontaneous yawning. We then administered the dopamine receptor an
tagonists L-741626 and nafadotride, which possess relative selectivity for
D-2 and Dg receptors, respectively, prior to injections of dopamine agonist
s into the Acb. Nafadotride significantly reduced the locomotor-enhancing e
ffects elicited by the coadministration of SKF 38393 and the D-2-class rece
ptor agonist (+)-PD 128907 into the Acb, and also attenuated the effects in
duced by the combination of SKF 38393 and bromocriptine, although not signi
ficantly so. L-741626 mildly attenuated the locomotor effects elicited by b
oth drug combinations. Taken together, these results suggest that both D-2
and D-3 receptors in the Acb contribute to the expression of heightened psy
chomotor activation. (C) 2000 Elsevier Science Inc. All rights reserved.